Search for: "KV Pharmaceutical Company" Results 1 - 20 of 67
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
6 Sep 2012, 5:25 pm by FDABlog HPM
In early August, KV announced that the company filed for Chapter 11 bankruptcy protection. [read post]
17 Aug 2012, 6:41 am by Reed Allmand
Louis based KV Pharmaceutical files for Chapter 11 bankruptcy protection after dealing with manufacturing issues along with weak sales of its birth control drug Makena. [read post]
9 Jul 2012, 2:00 am by Kara OBrien
We also discuss a First Circuit decision affirming the dismissal of a securities fraud action against Textron; a Second Circuit ruling addressing the standard for pleading a failure to disclose “known uncertainties” under Item 303 of Regulation S-K; and an Eighth Circuit decision reversing the dismissal of a securities fraud action against KV Pharmaceutical Company. [read post]
9 Jul 2012, 2:00 am by Kara OBrien
We also discuss a First Circuit decision affirming the dismissal of a securities fraud action against Textron; a Second Circuit ruling addressing the standard for pleading a failure to disclose “known uncertainties” under Item 303 of Regulation S-K; and an Eighth Circuit decision reversing the dismissal of a securities fraud action against KV Pharmaceutical Company. [read post]
8 Jul 2012, 7:01 pm by FDABlog HPM
Karst –       In a rare lawsuit against FDA involving the Orphan Drug Act of 1983, as amended, K-V Pharmaceutical Company (“KV”) and its wholly-owned subsidiary, Ther-Rx Corporation (“Ther-Rx”), filed a Complaint and a Motion for Temporary Restraining Order and Preliminary Injunction in the U.S. [read post]
1 Mar 2012, 9:30 pm by eithurburn@getnicklaw.com
  KV Pharmaceutical company will pay $17 million for allegedly accepting Medicaid reimbursement for drugs which were deemed “less than effective” by the FDA, and thus were ineligible for reimbursement by federal healthcare programs. [read post]
22 Feb 2012, 12:46 am by Kevin LaCroix
  Background Mark Hermelin was the CEO of K-V Pharmaceutical Company from 1975 to 2008, as well as a member of the company’s board from 1975 to 2010. [read post]
27 Dec 2011, 9:56 am by Max Kennerly, Esq.
” Janssen Pharmaceuticals argued it was “inherently prejudicial” to admit that email into the jury, as if drug companies had special license to lie to juries about deceiving the FDA. [read post]
15 Dec 2011, 11:28 am by admin
KV Pharmaceutical (KV), the parent company for Ethex Corporation (Ethex), this month agreed to pay $17 million to settle claims that Ethex of violated the False Claims Act when it allegedly reported false information to the Centers for Medicare and Medicaid Services (CMS). [read post]
12 Dec 2011, 1:21 pm by fraudfighters
  KV Pharmaceutical Company has agreed to pay $17 million to resolve allegations in a lawsuit brought by the Government against one of its former subsidiaries, Ethex Corporation. [read post]
9 Dec 2011, 12:52 pm by Ed Wallis
KV PHARMACEUTICAL SETTLES FALSE CLAIMS SUIT FOR $17 MILLION As False Claims Act lawyers, we recently read a news story on a for-profit company that sought reimbursement from the federal government for unapproved medications. [read post]
6 Dec 2011, 8:10 pm by eithurburn@getnicklaw.com
Louis-Based KV Pharmaceutical to Pay $17 Million to Settle False Claims Allegations Received Reimbursement for Unapproved Drugs" [read post]